看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。6 [6 ?8 T) _6 i7 B; w0 g! ~* U
, G6 Y1 Y( ^/ C* @
8 C5 y1 Z# b" J e2 LCurrently available feasibility data for possible combination strategies.
6 d' i0 X! H, G4 s! e————————————————————————————————# O( ?' ?) H: J( r3 a8 [
Combination Feasibility according to preliminary data
) |/ |" d) X8 a——————————————————————————————————
6 Y, H3 g7 G( SBevacizumab + sorafenib Yes, reduced dose
' ]& }# l- K6 u' {, OBevacizumab + sunitinib† No - F# V s" c" b& a
Bevacizumab + temsirolimus Yes
" `! U3 ^- ?& K5 mBevacizumab + everolimus Yes
3 \. K9 q* ?1 \5 eSorafenib + sunitinib ? , C9 F. f. U8 L6 `5 p6 l
Sorafenib + temsirolimus Yes, reduced dose
& U# R% v0 m& K) j, ASorafenib + everolimus Yes, reduced dose
: f# M( E. f5 R( g# gSunitinib + temsirolimus† No
% [1 k9 H6 |: w% v) p5 O8 G- G! d9 {Sunitinib + everolimus ? - R; X9 S M4 Y
Temsirolimus + everolimus ? ! a; w% u; I' Z* q$ h8 a" g+ e1 w
————————————————————9 m. T) k' {9 D! T% O4 r; o
†Led to US FDA warning.$ }& \* s R9 x, w' ]1 T& `
?: As yet unattempted combination.
4 m" P. N7 x% C2 h$ M. F+ v( q |